Biochemistry

Latest Content

How COVID-19 kills: a tale of two conditions

Steve Walton, explains why he believes the majority of patients that die after being infected with SARS CoV-2 virus infection do not die from respiratory failure, but because of a systemic multi orga…

News

Computational model could help translate drugs from animal studies to human

About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn's disease, end up becoming resistant or unresponsive to it.

Scientists might be able to catch problems…

In Depth

The great vaccine paradox

by Dermot Martin

What happens if the best defence against a virus develops an image problem? As we all await the potential freedoms that could be unlocked by a COVID-19 vaccine, Dermot Martin consid…

Comment And Analysis

How COVID-19 kills: a tale of two conditions

Steve Walton, explains why he believes the majority of patients that die after being infected with SARS CoV-2 virus infection do not die from respiratory failure, but because of a systemic multi orga…

Interviews

Encapsulating the COVID-19 vaccine race: the investor

Having worked with Stabilitech in various capacities over the past decade, Colin Maltby, Director of First Sentinel was uniquely positioned to understand the depth and breadth of the COVID-19 vaccine…